WARF: P08238US

  • Assigned to WARF as biological material.

Polyclonal Antibodies to CARM1


Wei Xu

The Wisconsin Alumni Research Foundation (WARF) is seeking commercial partners interested in developing polyclonal antibodies to the enzyme CARM1.
OVERVIEWThe enzyme CARM1 (coactivator associated arginine methyltransferase1) plays an important role in controlling development and cell growth. This nuclear hormone receptor co-activator is involved in the activation of several transcription factors, including NF-kB, p53, E2F1 and steroid receptors, such as the estrogen receptors. Standard analysis techniques, such as immunohistochemistry, can be used to improve our understanding of the function of CARM1 in vivo; however, high quality antibodies are needed for these analyses.
THE INVENTIONA UW-Madison researcher has developed polyclonal antibodies to CARM1. These antibodies were isolated from rabbit serum and have been thoroughly tested for various applications.
  • Immunohistochemistry, immunofluorescence, Western blot and chromatin immunoprecipitation analyses
For More Information About the Inventors
Contact Information
For current licensing status, please contact Jennifer Gottwald at or 608-960-9854.
The WARF Advantage

Since its founding in 1925 as the patenting and licensing organization for the University of Wisconsin-Madison, WARF has been working with business and industry to transform university research into products that benefit society. WARF intellectual property managers and licensing staff members are leaders in the field of university-based technology transfer. They are familiar with the intricacies of patenting, have worked with researchers in relevant disciplines, understand industries and markets, and have negotiated innovative licensing strategies to meet the individual needs of business clients.